PTPRC and breast carcinoma: In this study of a metastatic breast cancer patient, we present genomic and protein expression evidence for a distinct CTC population expressing CD45 as well as a suite of immune cell markers, including T-cell lineage markers, CD3 and CD4, and the “stem-like” and cell surface adhesion protein, CD44.